ADVERTISEMENT

China Approves First Homegrown Alzheimer’s Drug for Sale

China Approves First Homegrown Alzheimer’s Drug for Sale

Published
Fit
2 min read
China Approves First Homegrown Alzheimer’s Drug for Sale

China has approved the first home-grown drug for the treatment of "mild to moderate Alzheimer's disease (AD) and improving cognitive function", according to its developers.

The new drug, Oligomannate (GV-971), is the first to be approved for Alzheimer’s disease globally since 2003.

The drug has been developed by Green Valley Pharmaceutical Co. along with Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences.

Oligomannate will provide a new treatment option to fight Alzheimer's disease for patients and is expected to be available in China by the end of 2019, Green Valley Pharmaceutical said on Saturday, 2 November.

A multi-centre global phase 3 clinical trial with sites in the US, Europe and Asia is planned to be initiated in early 2020 to support global regulatory filing of Oligomannate.

An effective treatment for Alzheimer's that affects about 48 million people in the world could easily become a big hit globally.

China's National Medical Products Administration granted Oligomannate fast-track review in November 2018.

Over 800 patients with the diagnosis of mild to moderate Alzhemer’s disease completed the Phase 3 clinical trial conducted in 34 tier-1 hospitals across China.

Results of the 36-week-long study showed that Oligomannate can improve cognitive function in mild-to-moderate Alzheimer's disease patients as early as week 4 and the benefit was sustained at each follow-up assessment visit.

Alzheimer's disease is a progressive brain disorder that impairs memory, affecting the ability of patients to carry out simple tasks.

(This story was auto-published from a syndicated feed. No part of the story has been edited by FIT.)

(Delhi is in a public health emergency and schools have been shut. The air outside is visibly toxic - how has the hazardous air #pollution impacted you? Write down your #PollutionKaSolution and send it to us at FIT@thequint.com. )

(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)

(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)

We'll get through this! Meanwhile, here's all you need to know about the Coronavirus outbreak to keep yourself safe, informed, and updated.

Liked this story? We'll send you more. Subscribe to The Quint's newsletter and get selected stories delivered to your inbox every day. Click to get started.

The Quint is available on Telegram & WhatsApp too, click to join.

ADVERTISEMENT
Speaking truth to power requires allies like you.
Become a Quint Insider
25
100
200

or more

PREMIUM

3 months
12 months
12 months
Check Insider Benefits
ADVERTISEMENT
Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!
ADVERTISEMENT
×
×